Philip Morris To Acquire Israeli Cannabis Inhaler Company Syqe Medical For Up To $650 Million
If the medical cannabis inhaler passes clinical trials and receives FDA approval, Philip Morris will acquire all the shares of Syqe Medical for $650 million.
A picture taken on August 21, 2018 shows the research and development campus of cigarette and … [+] tobacco manufacturing company Philip Morris International, in Neuchatel, western Switzerland. Big…